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Abstract 
Background 
Coronary artery disease (CAD) is frequently seen in patients suffering from severe 
aortic valve stenosis (AS), as both pathologies share the same pathophysiology. In a 
transcatheter aortic valve implantation (TAVI) work-up, patients beneficiate from both 
computed tomography angiography (CTA) and invasive coronary angiography (ICA). 
Some studies evaluated the performance of CTA to diagnose CAD among patients 
undergoing TAVI and showed interesting results1-4. Nevertheless, data remain scarce 
and this diagnostic method is not validated in this population. In this context, we 
thought to evaluate the diagnostic performance of CTA to diagnose CAD among 
patients selected for TAVI. 
Methods 
A total of 199 patients that had a TAVI in the Lausanne University Hospital between 
the 1st of June 2013 and the 31st of December 2017 were retrospectively included. 
Exclusion criteria were coronary artery bypass graft (CABG) prior to CTA and 
unavailable CTA images. Finally, 127 patients were included. Two independent 
radiologists – blinded for ICA report – were asked to read the CTA of these patients 
and to indicate the presence of ≥50% and ≥70% stenosis in the 4 main coronary 
vessels. Their evaluation was then compared with ICA reports and analyses were 
performed at vessel and patient levels. 
Results 
A total of 342 vessels were analyzable. Based on ICA, significant CAD (at least 1 
≥50% stenosis) was present in 49 (38.6%) patients. Severe CAD (≥70% stenosis) 
was found in 29 (22.8%) patients. Sensitivity, specificity, positive predictive value, 
negative predictive value and accuracy of CTA to diagnose significant CAD were 
81.1%, 87.9%, 44.8%, 97.5% and 87.1% at vessel level using the cut-off of 50% and 
42.8%, 97.8%, 56.3%, 96.3% and 94.4% for severe CAD, using the cut-off of 70%. At 
patient level, sensitivity, specificity, positive and negative predictive values were 
respectively 84.6%, 64.6%, 56.4% and 88.6% for significant CAD. 
Conclusion 
Pre-TAVI CTA shows good performance to rule out significant and severe CAD and 
could be used as a gatekeeper for ICA. Positive findings on CTA should be 
confirmed with ICA given the low positive predictive value. 
 
Keywords: computed tomography angiography, coronary artery disease, 
transcatheter aortic valve implantation, aortic valve stenosis.  
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Background 
Aortic valve stenosis and coronary artery disease 
Aortic valve stenosis (AS) is currently the most frequent form of valvular heart 
disease in European countries5. In population-based studies, the prevalence of at 
least moderate AS is estimated at 2.8% among >75 years old people in developed 
countries and is bound to increase in the next years with the constant aging of the 
population6. The prognosis of a severe AS becomes unfortunately really poor as 
soon as the patient becomes symptomatic, with a mortality rate of about 25% per 
year7. A valve replacement must therefore quickly be considered. Currently, there are 
two different ways to change an aortic valve: surgical aortic valve replacement 
(SAVR) and transcatheter aortic valve replacement (TAVR), also known as 
transcatheter aortic valve implantation (TAVI). Initially, as it was recommended in the 
guidelines of the European Society of Cardiology of 2012, TAVI procedure was only 
performed as an alternative to SAVR in patients who had been assessed as 
inoperable by a Heart Team or if their surgical risk was considered very high8. As of 
today, TAVI tend to take a more important place in the treatment of severe aortic 
valve stenosis. As a matter of proof, some recent studies showed that it was not 
inferior to SAVR for intermediate risk patients in terms of 2 years mortality and 
stroke9, 10. In the most recently published (2017) European guidelines for the 
management of valvular heart disease, these indications remain present and other 
criteria such as an age of more than 75 years old are now criteria in favor of a 
percutaneous replacement11. 
It is not uncommon to find concomitant coronary artery disease (CAD) in patients 
suffering from severe AS, as both pathologies share the same pathophysiology and 
risk factors, which are mostly age, male sex, tobacco, arterial hypertension, diabetes 
mellitus and hyperlipidemia12, 13. Indeed, the early lesion of degenerative aortic 
stenosis is an inflammatory process relatively similar to atherosclerosis14. Therefore, 
it is even more common to find CAD among patients who have been selected for a 
TAVI procedure, as they are usually older and tend to have more comorbidities than 
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patients undergoing SAVR. The exact prevalence of CAD in patients undergoing 
TAVI is not known as there are important disparities in the definition of CAD among 
the different studies and variability in the assessment of coronary stenoses by 
angiography, but it stands somewhere between 34 and 75%15. As a matter of 
consequence, it is important to search actively for coronary artery disease in patients 
suffering from severe aortic valve stenosis before any intervention as both 
pathologies are closely related. 
Computed tomography angiography 
In a classical TAVI workup, patients benefit from a computed tomography 
angiography (CTA) to evaluate the dimensions of the aorta, the aortic annulus, and 
the peripheral vascular accesses and from an invasive coronary angiography (ICA), 
to search for CAD16. The CTA performed in a TAVI workup is different from a 
coronary CTA, whose main and only goal is to show precise images of the coronary 
arteries. A coronary CTA requires most of the time a heart rate control with beta-
blockers to reach an ideal heart rate of less than 65 bpm, and vessel dilatation with 
nitroglycerin17, 18. None of those specific dispositions figures in the pre-TAVI CTA 
protocol, as they are usually contra-indicated in patients suffering from severe aortic 
valve stenosis as they don’t tolerate well a diminution in preload. 
The comparison between coronary CTA and ICA to diagnose CAD was realized in 
multiple studies and showed a very good negative predictive value, from 96 to 
100%19. Coronary CTA is recommended to rule out CAD in patients with low to 
intermediate pre-test probabilities19, 20. On the other hand, stenoses visualized on 
coronary CTA need to be confirmed with ICA as the positive predictive value of CTA 
is ranged from 69 to 93%19. Patients selected for TAVI tend to have a significantly 
higher probability of CAD and heavier coronary calcifications than other patients. 
Even though those calcifications are known to cause artifacts on coronary images, 
the performance of coronary CTA with newer CT systems was proven to remain high 
in case of severe coronary calcifications21, 22. Nevertheless, the CT-scan realized in a 
TAVI workup is still not used to diagnose CAD and an ICA is systematically 
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performed. Ruling out CAD with CTA could minimize the global cost of a TAVI 
procedure and reduce the total contrast product volume injected (which is clearly 
beneficial in a population with frequently impaired renal function). It could also have a 
positive effect in term of morbidity and mortality, as ICA is still an invasive procedure 
with possible catheter-related complications. 
Some studies evaluated the performance of CTA to diagnose CAD among patients 
undergoing TAVI and showed interesting results1-4. Nevertheless, it is not yet 
validated. In this context, we thought to evaluate the diagnostic performance of CTA 
to diagnose CAD among patients selected for TAVI. 
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Methods 
Study design and population 
This is a retrospective study to evaluate the performance of computed tomography 
angiography in the diagnosis of coronary artery disease in patients undergoing 
transcatheter aortic valve implantation in the Lausanne University Center Hospital 
from the 1st of June 2013 to the 31st of December 2017. To meet our inclusion 
criteria, patients also had to give their written consent to be included in our registry.  
CTA protocol and analysis 
CT-scans were all performed using at least a 64-row detector CT-scanner. 
Retrospective ECG-gating was used for coronary CTA. No heart rate control or 
vasodilatation were used prior to the procedure. 
CTA images were retrospectively read by two radiology residents experienced in 
cardiovascular CT imaging. They were blinded from ICA images and results. 15% of  
images were randomly selected and read by both of them separately to determine 
the inter-observer variability using the κ of Cohen test. They evaluated the four main 
coronary arteries of each patient (right coronary artery, left main artery, left circumflex 
artery and left anterior descending artery), which makes a total of 508 vessels 
analyzed. Firstly, the quality of each vessel was qualified as optimal, suboptimal or 
unanalyzable in term of delineation between lumen and wall of the artery, filling with 
contrast material and opacification quality. Then, CAD analysis was realized on 
vessels whose quality was rated as optimal or suboptimal. Therefore, lumen diameter 
reductions were searched in those four main arteries and the following classification 
was applied on all of them: no significant CAD (0-49% lumen diameter reduction), 
moderate CAD (50-69% lumen diameter reduction), severe CAD (70-99% lumen 
diameter reduction or occlusion). If there was more than one stenosis on a vessel, 
only the most severe one was taken into account. Arteries were analyzed until a 
distal limiting diameter of 2.5mm, as stenoses present further wouldn't have any 
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clinical relevance. The Agatston Calcium Score was also calculated in the coronary 
arteries to give us an idea of the amount of calcium present in the arteries of our 
patients. 
ICA protocol and analysis 
Every patient beneficiated from an ICA in accordance with the usual procedure of our 
institution. All standard views were obtained. The ICA images were retrospectively 
read by an experienced interventional cardiologist and/or a student in master thesis 
under supervision. Both were blinded to CTA images and results. A CAD visual 
analysis was performed in each vessel using the same classification as for the CTA 
analysis. ICA images were also read until a distal limiting diameter of 2.5mm. 
Statistical analysis 
Statistical analysis was carried out using SPSS 24.0 software (SPSS Inc., Chicago, 
Illinois). Clinical characteristics of the patients were gathered from a database 
created and completed by the cardiology department of the Lausanne University 
Hospital for the SWISS TAVI registry. The SWISS TAVI Registry is a national, multi-
center, prospective cohort study collecting clinical characteristics of patients 
undergoing transcatheter aortic valve implantation (TAVI) in Switzerland. The study 
was approved by the ethic committee of the Bern University Center. Continuous 
variables were expressed as means ± standard deviation or medians (P25; P75) 
depending on their distribution while categorical variables were expressed as 
frequencies (percentage). The inter-observer variability was calculated using the κ of 
Cohen test, for the quality assessment and for the diagnosis of significant CAD at 
vessel level.  
Using ICA as gold standard, the performance of CTA to detect CAD among our 
patients was evaluated in terms of sensitivity (SN), specificity (SP), positive predictive 
value (PPV), negative predictive value (NPV) and accuracy (ACC). It was expressed 
as percentage. We decided to use two different cut-offs to evaluate this performance, 
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as they are the most commonly used in the literature: ≥50% lumen diameter 
reduction, which corresponds to significant CAD and ≥70% lumen diameter 
reduction, which corresponds to severe CAD. We conducted an analysis at vessel 
level. Subgroup analyses based on quality were made at vessel level with a 
subgroup with vessels presenting an optimal quality on CTA and another one with 
those presenting a suboptimal quality on CTA images. We also made analyses at 
patient level, calculating the capacity of CTA to exclude or to diagnose CAD. A 
patient was considered positive for CAD when at least one vessel showed CAD. We 
also used two different cut-offs: ≥50% lumen diameter reduction for significant CAD 
and ≥70% lumen diameter reduction for severe CAD. 
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Results 
Patients characteristics 
199 patients met our inclusion criteria. A part of those patients had the whole or part 
of the TAVI workup in a peripheral hospital and the CTA or/and ICA images of 44 of 
them were not available for analysis. We also decided to exclude 28 patients that had 
a coronary artery bypass graft prior to the TAVI workup. The study was therefore 
realized on a total of 127 patients (Figure 1). 
 
 
Figure 1. Flowchart of the study design 
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Characteristics of patients included in this study are summarized in Table 1. Mean 
age was 82.3 years ±7.3. Dyslipidemia and arterial hypertension, which are two 
important risk factors for AS, were present among the majority of patients included in 
the study, with prevalence of respectively 69 (54.3%) and 98 (77.2%). The median 
value of estimated glomerular filtration rate (calculated with the Cockroft and Gault 
formula) was 43 ml/min/1.73m2 (36; 58). There were 21 patients with a history of 
percutaneous coronary intervention and the median mortality risk after a cardiac 
intervention estimated with the EuroSCORE II was 3.7% (2.3; 5.4). The median 
Agatston Calcium Score was 703 (195; 1665) but was calculated only among 83 
(65.4%) of patients. It could not be calculated in 21 (16.5%) patients because of an 
important noise, that the software misinterprets as calcium and in 23 (18.1%) patients 
because the dedicated native sequence was not available. Based on ICA analysis, 
49 (38.6%) of patients were suffering from significant CAD and 29 (22.8%) of them 
had at least one severe stenosis (≥70%). A total of 508 vessels were analyzed and a 
significant stenosis was found in 67 of them. 
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Patients characteristics (n=127) 
Variable Result 
Age (years) 82.3 ±7.3  
Male 49 (38.6%) 
BMI (kg/m2) 26.5 ±5.1  
Dyslipidemia 69 (54.3%) 
Arterial hypertension 98 (77.2%) 
Diabetes mellitus 36 (28.3%) 
COPD 15 (11.8%) 
History of PCI 21 (16.5%) 
eGFR (ml/min/1.73m) 43 (36; 58) 
EuroSCORE II (%)1 3.7 (2.3; 5.4) 
Agatston Calcium Score 703 (195; 1665) 
Coronary artery disease 49 (38.6%) 
1 vessel disease 33 (26%) 
2 vessels disease 14 (10.9%) 
3 vessels disease 2 (1.6%) 
 
Table 1. BMI body mass index, COPD chronic obstructive pulmonary disease, eGFR 
estimated glomerular filtration rate, PCI percutaneous coronary intervention. 
Age and BMI are expressed in mean ± standard deviation as they are normally distributed 
according to Kolmogorov-Smirnof. eGFR, EuroSCORE II and Agatston Calcium Score are 
expressed in median (P25; P75) as they are not normally distributed according to 
Kolmogorov-Smirnof. Categorical variables are expressed in number (percentage). 
1 Mean Euroscore II was calculated among 101 (79.5%) patients. Missing data could not be 
completed in the former TAVI database. 
2 Mean Agatston Calcium Score was calculated among 83 (65.4%) patients. The score was 
sometimes uncalculable because of important noise (that the software misinterpret as 
calcium) or because the dedicated native sequence was not performed). 
CTA performance 
A κ of 0.51 was found for the quality assessment, which corresponds to a moderate 
inter-observer agreement. For the diagnosis of significant CAD at vessel level, κ was 
calculated at 0.61, which corresponds to a good inter-observer agreement. Both 
agreements were significant with a p-value <0.05. 
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First of all, as mentioned in methods, the CTA images quality of each artery was 
assessed using a 3 items scale: optimal, suboptimal or unanalyzable. 166 vessels 
(32.7%) were rated as unanalyzable on CTA and were excluded from the CAD 
analysis, meaning that the analysis for CAD was performed on 342 vessels. The 
quality of images of the LM were the most optimal, with 63 (49.6%) vessels rated as 
optimal, which is not surprising, as this vessel is much shorter than the other ones. 
On 127 patients included in the study, the CTA of 74 patients (58.3%) had 4 coronary 
vessels analyzable, 9 (7.1%) had 3 vessels analyzable, 8 (6.3%) had 2 vessels 
analyzable, 3 (2.4%) patients had only one vessel analyzable and for 33 (25.8%) of 
them, all four arteries were unanalyzable. CTA images quality results are visible in 
detail on Table 2 and represented in Figure 2. 
CTA images quality results 
Vessel Quality (n (%)) 
  Optimal Suboptimal Unanalyzable 
RCA (n=127) 29 (22.8%) 52 (40.9%) 46 (36.2%) 
LM (n=127) 63 (49.6%) 29 (22.7%) 35 (27.3%) 
LCX (n=127) 24 (18.8%) 59 (22.8%) 44 (34.6%) 
LAD (n=127) 25 (19.7%) 61 (48%) 41 (32.3%) 
All Vessels (n=508) 141 (27.8%) 201 (39.6%) 166 (32.7%) 
        
Table 2. LAD left anterior descending artery, LCX left circumflex artery, LM left main artery, 
RCA right coronary artery. 
 
  
14 
 
Figure 2. Repartition of the vessels according to the quality of their CTA 
images 
The CTA performance to diagnose CAD was evaluated on 342 vessels on a per 
vessel analysis. To diagnose significant CAD at all vessels level, SN was 81.1%, SP 
was 87.9%, PPV was 44.8%, NPV was 97.5% and ACC was 87.1%. Analysis was 
also done for each vessel separately, with a total of 81 RCA, 92 LM, 83 LCX and 86 
LAD analyzed. The results can be seen on Table 3. The performance of CTA was 
also evaluated to diagnose severe CAD (cut-off for diameter reduction ≥70%). 
Results figure in Table 4. 
We also conducted a subgroup analysis at vessel level depending on the quality of 
images on CTA. The performance of CTA was analyzed in a group of vessels whose 
CTA images quality was rated as optimal and in another group of vessels whose 
CTA images quality was rated as suboptimal. We found a slightly better performance 
for images of optimal quality to rule out CAD, with a NPV of 99.2% versus 95.9% in 
favor of optimal quality vessels for significant stenoses (≥50%) and 98.5% versus 
94.7%, also in favor of optimal quality vessels, for severe stenoses (≥70%). A least 
one significant stenosis was found in 16.4% of suboptimal quality vessels but only in 
2.8% of optimal quality vessels. Detailed results can be seen on Table 5, Table 6 
and Figure 3. 
141 (27.8%)
201 (39.6%)
166 (32.7%)
All vessels quality
optimal
suboptimal
unanalyzable
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 Table 3. FN false negative, FP false positive, LAD left anterior descending artery, LCX left circumflex artery, LM left main artery, number NPV 
negative predictive value, PPV positive predictive value, RCA right coronary artery, TN true negative, TP true positive. 
 
CTA performance to diagnose severe CAD (≥70% diameter reduction) among TAVI patients 
  N TP (n) TN (n) FP (n) FN (n) Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%) 
RCA 81 4 74 2 1 80 97.4 66.7 98.7 96.3 
LM1 92 0 91 0 1 - - - - - 
LCX 83 1 77 3 2 33.3 96.3 25 97.5 94 
LAD 86 4 72 2 8 33.3 97.3 66.7 90 88.4 
All vessels 342 9 314 7 12 42.8 97.8 56.3 96.3 94.4 
Table 4. FN false negative, FP false positive, LAD left anterior descending artery, LCX left circumflex artery, LM left main artery, number NPV 
negative predictive value, PPV positive predictive value, RCA right coronary artery, TN true negative, TP true positive. 
1Sensitivity, specificity, positive predictive value, negative predictive value and accuracy could not be calculated for the left main artery as there 
was no severe stenosis on this artery. 
 
CTA performance to diagnose significant CAD (≥50% diameter reduction) among TAVI patients 
  N TP (n) TN (n) FP (n) FN (n) Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%) 
RCA 81 9 67 5 0 100 93.1 64.3 100 93.8 
LM 92 1 86 5 0 100 94.5 16.7 100 94.6 
LCX 83 3 67 11 2 60 85.9 26.7 97.1 84.3 
LAD 86 17 48 16 5 73.9 75 51.5 90.6 74.7 
All vessels 342 30 268 37 7 81.1 87.9 44.8 97.5 87.1 
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Subgroup analysis to diagnose significant CAD (≥50%) according to the quality of the vessels 
Quality N TP (n) TN (n) FP (n) FN (n) Sensitivity (%) Specificity (%) VPP (%) VPN (%) Accuracy (%) 
Optimal 141 3 126 11 1 75 91.7 21.4 99.2 91.4 
Suboptimal 201 27 142 26 6 81.8 84.5 50.9 95.9 84.1 
Table 5. FN false negative, FP false positive, LAD left anterior descending artery, LCX left circumflex artery, LM left main artery, number 
NPV negative predictive value, PPV positive predictive value, RCA right coronary artery, TN true negative, TP true positive. 
 
Subgroup analysis to diagnose severe CAD (≥70%) according to the quality of the vessels 
Quality N TP (n) TN (n) FP (n) FN (n) Sensitivity (%) Specificity (%) VPP (%) VPN (%) Accuracy (%) 
Optimal 141 1 135 3 2 33.3 97.8 25 98.5 96.4 
Suboptimal 201 8 179 4 10 44.4 97.8 66.7 94.7 93 
Table 6. FN false negative, FP false positive, LAD left anterior descending artery, LCX left circumflex artery, LM left main artery, number NPV 
negative predictive value, PPV positive predictive value, RCA right coronary artery, TN true negative, TP true positive. 
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Figure 3. Comparison of the performance of CTA to diagnose CAD between 
optimal and suboptimal quality vessels 
ACC accuracy, NPV negative predictive value, PPV positive predictive value, SN sensitivity, 
SP specificity.  
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The analysis at patient level was only performed in the 74 patients whose 4 arteries 
had an analyzable quality on CTA using the two stenosis cut-offs of 50 and 70%. 
CTA compared to ICA to diagnose 
significant CAD at patient level 
ICA 
no ≥50% stenosis 
at least one ≥50% 
stenosis 
CTA 
no ≥50% stenosis 31 4 
at least one ≥50% stenosis 17 22 
Table 7. 
For the 50% cut-off, the capacity of CTA to exclude significant CAD, which 
corresponds to the specificity, was 64.6%. Its capacity to diagnose significant CAD, 
which is the sensitivity, was 84.6%. Positive and negative predictive values were 
respectively 56.4 % and 88.6%. Of note, among the 26 patients with at least one 
≥50% stenosis, there was always at least one diseased vessel with concordance 
between ICA and CTA in 25 patients but in 1 patient, one lesion visualized on ICA 
was not observed on CTA but this latter showed a stenosis non-existing on ICA, 
meaning that for this patient, there was an agreement at patient level without any 
agreement at vessel level. 
CTA compared to ICA to diagnose 
severe CAD at patient level 
ICA 
no ≥70% stenosis 
at least one ≥70% 
stenosis 
CTA 
no ≥70% stenosis 57 7 
at least one ≥70% stenosis 3 7 
Table 8. 
For the 70% cut-off (severe CAD,) the sensitivity, specificity, positive and negative 
predictive values were respectively 50%, 95%, 70% and 89.1%. 
  
19 
Discussion 
Our study main findings can be summarized as followed: 
1) CTA shows very good accuracy and negative predictive value for the 
diagnosis of CAD among TAVI patients. Negative findings must therefore be 
considered as true negatives. 
2) CTA positive predictive value to diagnose CAD is low. Positive findings must 
therefore be confirmed with ICA. 
3) CTA tends to overdiagnose CAD among TAVI patients. 
The recent meta-analysis from Van Den Boogert and al. gathering 7 single center 
studies showed interesting results about performance of pre-TAVI CTA to diagnose 
significant CAD, especially to rule out CAD. At patient level, SN, SP, PPV and NPV 
were respectively 95, 65, 71 and 94%23. However, 6 out of these 7 studies included 
patients who beneficiated from a CABG prior to the pre-TAVI work-up. The only study 
that did exclude CABG patients was Rossi and al24. This study included 140 patients 
and showed similar results to ours in term of sensitivity, specificity, positive and 
negative predictive values. 
Our results confirm the fact that the negative predictive value of CTA to detect CAD 
is really good among patients selected for TAVI, with a NPV of 88.6%. However, CTA 
tends to overdiagnose CAD, with a capacity to exclude CAD of 64.6%, meaning that 
35.4% of positive findings are actually negative. As of today, in our daily practice, 
CTA is still not used to evaluate coronary arteries in the TAVI work-up. We must 
obviously wait for a higher level of evidence before we definitely use CTA to rule out 
CAD. However, we could ask ourselves if it would not be beneficial for patients 
suffering from severe renal failure to go "off-label" and start using CTA as a 
gatekeeper for ICA. A needed condition to do so would be that the radiologist reports 
a good image quality of coronary vessels. 
In our subgroup analysis, SN and PPV were higher in the suboptimal quality group 
than in the optimal one. This is explained by the fact that the prevalence of CAD was 
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much higher in suboptimal quality vessels than in those of optimal quality, which was 
expected. In optimal quality group, significant stenosis was only found in 4 arteries, 
when it was found in 33 arteries in suboptimal quality group. 
Limitations 
The number of unanalyzable vessels was much higher in our study than in those 
included in the meta-analysis of Van Den Boogert and al23. Indeed, 32.7% of vessels 
were unanalyzable in our study. Also, the inter-observer variability for quality was 
moderate. This probably comes from the fact that quality classification is really 
subjective and therefore can differ a lot from one observer to another.  
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Conclusion 
Pre-TAVI CTA showed good performance to rule out significant and severe CAD. 
However, it tends to overdiagnose it. In a TAVI work-up, coronary arteries should 
therefore be analyzed on CTA as it could be used as a gatekeeper for ICA if the 
quality of images is acceptable. This should be even more highly considered in 
patients with impaired renal function. 
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